INCB 018424-13C,15N2

INCB 018424-13C,15N2 Chemische Eigenschaften,Einsatz,Produktion Methoden

• Verwenden

  Labelled racemic analogue of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.

• Verwenden

  As labelled racemic analogue of Ruxolitinib (R702000), rac-Ruxolitinib-13C,15N2 is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.

INCB 018424-13C,15N2 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(7)Suppliers